Apilance Pharmaceuticals Private Limited

Apilance Pharmaceuticals Private Limited - business services in Mangrol, Gujarat, India. Directors, charges & compliance details.
CIN U47721GJ2023PTC147028 Incorporated 19 December 2023 ROC Ahmedabad HQ Mangrol, Gujarat, India
Active Private Limited Company
Data last updated
Revenue · FY 2025
₹24.85 Lakh
▲ 810% YoY
Net profit · FY 2025
₹36,467
Net margin 1.5%
EBITDA · FY 2025
₹1.36 Lakh
EBITDA margin 5.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Apilance Pharmaceuticals Private Limited

Data last updated:

Apilance Pharmaceuticals Private Limited is a private limited company based in Mangrol, Gujarat, India. It was incorporated on 19 December 2023.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U47721GJ2023PTC147028.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Anjani Kumari and Prabhat Kumar Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 808 Rami Park Society, Mangrol, Gujarat, India – 394210.

As per the financials filed for FY 2025, the company reported a revenue of ₹24.85 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹36,467 (net margin 1.5%) and EBITDA of ₹1.36 Lakh (EBITDA margin 5.5%).

Company details

CIN U47721GJ2023PTC147028
Registration Number 147028
Incorporation Date 19 December 2023
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Apilance Pharmaceuticals Private Limited's registered office is in Mangrol, Gujarat.

  • Registered Address
    808 Rami Park Society, Mangrol, Gujarat, India – 394210
Comprehensive company report
Apilance Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Apilance Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcycles

To see the full business activity and turnover split of Apilance Pharmaceuticals Private Limited, buy the company report.

Financials of Apilance Pharmaceuticals Private Limited

FY 2025 filings available

Apilance Pharmaceuticals Private Limited reported revenue of ₹24.85 Lakh (up 810% YoY) for FY 2025.

Revenue · FY 2025
₹24.85 Lakh ▲ 810%
Net profit · FY 2025
₹36,467 margin 1.5%
EBITDA · FY 2025
₹1.36 Lakh margin 5.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 810%

Revenue rose 810% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.36 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹36,467
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin5.5%
Net Profit Margin1.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Apilance Pharmaceuticals Private Limited, buy the company report.

Board of directors of Apilance Pharmaceuticals Private Limited

Apilance Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anjani KumariDirector19 Dec 20232 Years 10 MonthsCurrent
Prabhat Kumar SinghDirector19 Dec 20232 Years 10 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Apilance Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Apilance Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Apilance Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Anjani Kumari was appointed as Director on 19 Dec 2023.

AGM
Apilance Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Apilance Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Anjani Kumari was appointed as Director.
Appointed
Prabhat Kumar Singh was appointed as Director.
Incorporation
19 Dec 2023
Apilance Pharmaceuticals Private Limited was registered on 19 Dec 2023 with Roc Ahmedabad & aged 2 years 10 months as per MCA records.

Frequently asked questions

Apilance Pharmaceuticals is an active private limited company based in Mangrol, Gujarat, India. It was incorporated on 19 December 2023 (3+ years old) and is registered under CIN U47721GJ2023PTC147028.

Apilance Pharmaceuticals has 2 current directors:

The latest financial statements of Apilance Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Apilance Pharmaceuticals is U47721GJ2023PTC147028. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Apilance Pharmaceuticals was incorporated on 19 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Anjani Kumari was appointed as Director on 19 Dec 2023. Prabhat Kumar Singh was appointed as Director on 19 Dec 2023.

The registered office of Apilance Pharmaceuticals is at 808 Rami Park Society, Mangrol, Gujarat, India – 394210.

Apilance Pharmaceuticals can be reached at its registered office: 808 Rami Park Society, Mangrol, Gujarat, India – 394210.

Apilance Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Ahmedabad.